A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer
Clinical trial NCT07000305 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07000305
- Sponsor
- Tao Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2027-05-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.